18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
old 9 12 9 12 O
or 13 15 13 15 O
older 16 21 16 21 O

Able 0 4 22 26 O
to 5 7 27 29 O
swallow 8 15 30 37 O
and 16 19 38 41 O
retain 20 26 42 48 O
orally 27 33 49 55 O
administered 34 46 56 68 O
medication 47 57 69 79 O
and 58 61 80 83 O
does 62 66 84 88 O
not 67 70 89 92 O
have 71 75 93 97 O
any 76 79 98 101 O
clinically 80 90 102 112 O
significant 91 102 113 124 O
gastrointestinal 103 119 125 141 B-chronic_disease
abnormalities 120 133 142 155 I-chronic_disease
that 134 138 156 160 O
may 139 142 161 164 O
alter 143 148 165 170 O
absorption 149 159 171 181 B-chronic_disease
such 160 164 182 186 O
as 165 167 187 189 O
malabsorption 168 181 190 203 B-chronic_disease
syndrome 182 190 204 212 I-chronic_disease
or 191 193 213 215 O
major 194 199 216 221 B-treatment
resection 200 209 222 231 I-treatment
of 210 212 232 234 O
the 213 216 235 238 O
stomach 217 224 239 246 O
or 225 227 247 249 O
bowels 228 234 250 256 O

Any 0 3 257 260 O
serious 4 11 261 268 O
and/or 12 18 269 275 O
unstable 19 27 276 284 O
pre 28 31 285 288 O
- 31 32 288 289 O
existing 32 40 289 297 O
medical 41 48 298 305 O
( 49 50 306 307 O
aside 50 55 307 312 O
from 56 60 313 317 O
malignancy 61 71 318 328 B-cancer
exception 72 81 329 338 O
above 82 87 339 344 O
) 87 88 344 345 O
, 88 89 345 346 O
psychiatric 90 101 347 358 B-chronic_disease
disorder 102 110 359 367 I-chronic_disease
, 110 111 367 368 O
or 112 114 369 371 O
other 115 120 372 377 O
conditions 121 131 378 388 O
that 132 136 389 393 O
could 137 142 394 399 O
interfere 143 152 400 409 O
with 153 157 410 414 O
subject 158 165 415 422 O
's 165 167 422 424 O
safety 168 174 425 431 O
, 174 175 431 432 O
obtaining 176 185 433 442 O
informed 186 194 443 451 O
consent 195 202 452 459 O
or 203 205 460 462 O
compliance 206 216 463 473 O
to 217 219 474 476 O
the 220 223 477 480 O
study 224 229 481 486 O
procedures 230 240 487 497 O
, 240 241 497 498 O
in 242 244 499 501 O
the 245 248 502 505 O
opinion 249 256 506 513 O
of 257 259 514 516 O
the 260 263 517 520 O
investigator 264 276 521 533 O

Any 0 3 534 537 O
serious 4 11 538 545 O
known 12 17 546 551 O
immediate 18 27 552 561 O
or 28 30 562 564 O
delayed 31 38 565 572 O
hypersensitivity 39 55 573 589 O
reaction(s 56 66 590 600 O
) 66 67 600 601 O
to 68 70 602 604 O
GSK525762 71 80 605 614 B-allergy_name
or 81 83 615 617 O
idiosyncrasy 84 96 618 630 O
to 97 99 631 633 O
drugs 100 105 634 639 O
chemically 106 116 640 650 O
related 117 124 651 658 O
to 125 127 659 661 O
the 128 131 662 665 O
investigational 132 147 666 681 B-treatment
drug 148 152 682 686 I-treatment

At 0 2 687 689 O
least 3 8 690 695 O
3 9 10 696 697 B-lower_bound
months 11 17 698 704 I-lower_bound
has 18 21 705 708 O
elapsed 22 29 709 716 O
from 30 34 717 721 O
the 35 38 722 725 O
time 39 43 726 730 O
of 44 46 731 733 O
transplant 47 57 734 744 B-treatment

Baseline 0 8 745 753 B-clinical_variable
QTcF 9 13 754 758 I-clinical_variable
interval 14 22 759 767 I-clinical_variable
> 23 24 768 769 O
= 24 25 769 770 O
450 25 28 770 773 B-lower_bound
milliseconds 29 41 774 786 I-lower_bound

Cardiac 0 7 787 794 B-chronic_disease
abnormalities 8 21 795 808 I-chronic_disease
as 22 24 809 811 O
evidenced 25 34 812 821 O
by 35 37 822 824 O

Chemotherapy 0 12 825 837 B-treatment
regimens 13 21 838 846 I-treatment
given 22 27 847 852 O
continuously 28 40 853 865 O
or 41 43 866 868 O
on 44 46 869 871 O
a 47 48 872 873 O
weekly 49 55 874 880 O
basis 56 61 881 886 O
with 62 66 887 891 O
limited 67 74 892 899 O
potential 75 84 900 909 O
for 85 88 910 913 O
delayed 89 96 914 921 O
toxicity 97 105 922 930 O
within 106 112 931 937 O
the 113 116 938 941 O
last 117 121 942 946 B-upper_bound
2 122 123 947 948 I-upper_bound
weeks 124 129 949 954 I-upper_bound

Chemotherapy 0 12 955 967 B-treatment
regimens 13 21 968 976 I-treatment
with 22 26 977 981 O
delayed 27 34 982 989 O
toxicity 35 43 990 998 O
within 44 50 999 1005 O
the 51 54 1006 1009 O
last 55 59 1010 1014 B-upper_bound
4 60 61 1015 1016 I-upper_bound
weeks 62 67 1017 1022 I-upper_bound

Child 0 5 1023 1028 O
- 5 6 1028 1029 O
bearing 6 13 1029 1036 O
potential 14 23 1037 1046 O
and 24 27 1047 1050 O
agrees 28 34 1051 1057 B-contraception_consent
to 35 37 1058 1060 I-contraception_consent
use 38 41 1061 1064 I-contraception_consent
one 42 45 1065 1068 I-contraception_consent
of 46 48 1069 1071 I-contraception_consent
the 49 52 1072 1075 I-contraception_consent
contraception 53 66 1076 1089 I-contraception_consent
methods 67 74 1090 1097 I-contraception_consent
for 75 78 1098 1101 O
an 79 81 1102 1104 O
appropriate 82 93 1105 1116 O
period 94 100 1117 1123 O
of 101 103 1124 1126 O
time 104 108 1127 1131 O
( 109 110 1132 1133 O
as 110 112 1133 1135 O
determined 113 123 1136 1146 O
by 124 126 1147 1149 O
the 127 130 1150 1153 O
product 131 138 1154 1161 O
label 139 144 1162 1167 O
or 145 147 1168 1170 O
investigator 148 160 1171 1183 O
) 160 161 1183 1184 O
prior 162 167 1185 1190 O
to 168 170 1191 1193 O
the 171 174 1194 1197 O
start 175 180 1198 1203 O
of 181 183 1204 1206 O
dosing 184 190 1207 1213 O
to 191 193 1214 1216 O
sufficiently 194 206 1217 1229 O
minimize 207 215 1230 1238 O
the 216 219 1239 1242 O
risk 220 224 1243 1247 O
of 225 227 1248 1250 O
pregnancy 228 237 1251 1260 B-pregnancy
at 238 240 1261 1263 O
that 241 245 1264 1268 O
point 246 251 1269 1274 O

Clinically 0 10 1275 1285 O
significant 11 22 1286 1297 O
ECG 23 26 1298 1301 B-treatment
assessments 27 38 1302 1313 O
should 39 45 1314 1320 O
be 46 48 1321 1323 O
reviewed 49 57 1324 1332 O
by 58 60 1333 1335 O
the 61 64 1336 1339 O
site 65 69 1340 1344 O
cardiologist 70 82 1345 1357 O
prior 83 88 1358 1363 O
to 89 91 1364 1366 O
study 92 97 1367 1372 O
entry 98 103 1373 1378 O

Clinically 0 10 1379 1389 O
significant 11 22 1390 1401 O
conduction 23 33 1402 1412 B-chronic_disease
abnormalities 34 47 1413 1426 I-chronic_disease
or 48 50 1427 1429 O
arrhythmias 51 62 1430 1441 B-chronic_disease
, 62 63 1441 1442 O
subjects 64 72 1443 1451 O
with 73 77 1452 1456 O
Bundle 78 84 1457 1463 B-chronic_disease
Branch 85 91 1464 1470 I-chronic_disease
Block 92 97 1471 1476 I-chronic_disease

Consult 0 7 1477 1484 O
the 8 11 1485 1488 O
GSK 12 15 1489 1492 B-clinical_variable
Medical 16 23 1493 1500 O
Monitor 24 31 1501 1508 O
if 32 34 1509 1511 O
unsure 35 41 1512 1518 O
whether 42 49 1519 1526 O
second 50 56 1527 1533 B-cancer
malignancies 57 69 1534 1546 I-cancer
meet 70 74 1547 1551 O
requirements 75 87 1552 1564 O
specified 88 97 1565 1574 O
above 98 103 1575 1580 O

Current 0 7 1581 1588 O
use 8 11 1589 1592 O
of 12 14 1593 1595 O
a 15 16 1596 1597 O
prohibited 17 27 1598 1608 O
medication 28 38 1609 1619 B-treatment
or 39 41 1620 1622 O
requires 42 50 1623 1631 O
any 51 54 1632 1635 O
of 55 57 1636 1638 O
these 58 63 1639 1644 O
medications 64 75 1645 1656 B-treatment
during 76 82 1657 1663 O
treatment 83 92 1664 1673 B-treatment
with 93 97 1674 1678 O
the 98 101 1679 1682 O
investigational 102 117 1683 1698 B-treatment
drugs 118 123 1699 1704 I-treatment

Currently 0 9 1705 1714 O
receiving 10 19 1715 1724 O
cancer 20 26 1725 1731 B-treatment
therapy 27 34 1732 1739 I-treatment
( 35 36 1740 1741 O
chemotherapy 36 48 1741 1753 B-treatment
, 48 49 1753 1754 O
radiation 50 59 1755 1764 B-treatment
therapy 60 67 1765 1772 I-treatment
, 67 68 1772 1773 O
immuno- 69 76 1774 1781 B-treatment
therapy 77 84 1782 1789 I-treatment
, 84 85 1789 1790 O
biologic 86 94 1791 1799 B-treatment
therapy 95 102 1800 1807 I-treatment
, 102 103 1807 1808 O
hormonal 104 112 1809 1817 B-treatment
therapy 113 120 1818 1825 I-treatment
, 120 121 1825 1826 O
surgery 122 129 1827 1834 B-treatment
, 129 130 1834 1835 O
and/or 131 137 1836 1842 O
tumour 138 144 1843 1849 B-treatment
embolization 145 157 1850 1862 I-treatment
) 157 158 1862 1863 O

ECG 0 3 1864 1867 B-treatment
findings 4 12 1868 1876 O
or 13 15 1877 1879 O
assessments 16 27 1880 1891 O

Eastern 0 7 1892 1899 B-clinical_variable
Cooperative 8 19 1900 1911 I-clinical_variable
Oncology 20 28 1912 1920 I-clinical_variable
Group 29 34 1921 1926 I-clinical_variable
( 35 36 1927 1928 I-clinical_variable
ECOG 36 40 1928 1932 I-clinical_variable
) 40 41 1932 1933 I-clinical_variable
performance 42 53 1934 1945 I-clinical_variable
status 54 60 1946 1952 I-clinical_variable
of 61 63 1953 1955 O
< 64 65 1956 1957 O
= 65 66 1957 1958 O
1 66 67 1958 1959 B-upper_bound

Evidence 0 8 1960 1968 O
of 9 11 1969 1971 O
hemoptysis 12 22 1972 1982 B-chronic_disease
within 23 29 1983 1989 O
the 30 33 1990 1993 O
last 34 38 1994 1998 B-upper_bound
7 39 40 1999 2000 I-upper_bound
days 41 45 2001 2005 I-upper_bound

Evidence 0 8 2006 2014 O
of 9 11 2015 2017 O
severe 12 18 2018 2024 O
of 19 21 2025 2027 O
uncontrolled 22 34 2028 2040 B-chronic_disease
infection 35 44 2041 2050 I-chronic_disease

Evidence 0 8 2051 2059 O
of 9 11 2060 2062 O
severe 12 18 2063 2069 O
or 19 21 2070 2072 O
uncontrolled 22 34 2073 2085 O
systemic 35 43 2086 2094 B-chronic_disease
diseases 44 52 2095 2103 I-chronic_disease
( 53 54 2104 2105 O
e.g. 54 58 2105 2109 O
, 58 59 2109 2110 O
unstable 60 68 2111 2119 O
or 69 71 2120 2122 O
uncompensated 72 85 2123 2136 O
respiratory 86 97 2137 2148 B-chronic_disease
, 97 98 2148 2149 O
hepatic 99 106 2150 2157 B-chronic_disease
, 106 107 2157 2158 O
renal 108 113 2159 2164 B-chronic_disease
, 113 114 2164 2165 O
cardiac 115 122 2166 2173 B-chronic_disease
disease 123 130 2174 2181 I-chronic_disease
, 130 131 2181 2182 O
or 132 134 2183 2185 O
clinically 135 145 2186 2196 O
significant 146 157 2197 2208 O
bleeding 158 166 2209 2217 B-chronic_disease
episodes 167 175 2218 2226 I-chronic_disease
) 175 176 2226 2227 O

Female 0 6 2228 2234 B-gender
subjects 7 15 2235 2243 I-gender
must 16 20 2244 2248 O
agree 21 26 2249 2254 B-contraception_consent
to 27 29 2255 2257 I-contraception_consent
use 30 33 2258 2261 I-contraception_consent
contraception 34 47 2262 2275 I-contraception_consent
until 48 53 2276 2281 O
at 54 56 2282 2284 O
least 57 62 2285 2290 O
7 63 64 2291 2292 B-lower_bound
months 65 71 2293 2299 I-lower_bound
after 72 77 2300 2305 I-lower_bound
the 78 81 2306 2309 O
last 82 86 2310 2314 O
dose 87 91 2315 2319 O
of 92 94 2320 2322 O
study 95 100 2323 2328 O
medication 101 111 2329 2339 B-treatment

Female 0 6 2340 2346 B-gender
subjects 7 15 2347 2355 I-gender
who 16 19 2356 2359 O
are 20 23 2360 2363 O
lactating 24 33 2364 2373 O
must 34 38 2374 2378 O
discontinue 39 50 2379 2390 O
nursing 51 58 2391 2398 O
prior 59 64 2399 2404 O
to 65 67 2405 2407 O
the 68 71 2408 2411 O
first 72 77 2412 2417 O
dose 78 82 2418 2422 O
of 83 85 2423 2425 O
study 86 91 2426 2431 B-treatment
treatment 92 101 2432 2441 I-treatment
and 102 105 2442 2445 O
must 106 110 2446 2450 O
refrain 111 118 2451 2458 O
from 119 123 2459 2463 O
nursing 124 131 2464 2471 O
throughout 132 142 2472 2482 O
the 143 146 2483 2486 O
treatment 147 156 2487 2496 O
period 157 163 2497 2503 O
and 164 167 2504 2507 O
for 168 171 2508 2511 O
5 172 173 2512 2513 O
half 174 178 2514 2518 O
- 178 179 2518 2519 O
lives 179 184 2519 2524 O
of 185 187 2525 2527 O
GSK525762 188 197 2528 2537 B-treatment

Females 0 7 2538 2545 B-gender
on 8 10 2546 2548 O
hormone 11 18 2549 2556 B-treatment
replacement 19 30 2557 2568 I-treatment
therapy 31 38 2569 2576 I-treatment
( 39 40 2577 2578 I-treatment
HRT 40 43 2578 2581 I-treatment
) 43 44 2581 2582 I-treatment
and 45 48 2583 2586 O
whose 49 54 2587 2592 O
menopausal 55 65 2593 2603 O
status 66 72 2604 2610 O
is 73 75 2611 2613 O
in 76 78 2614 2616 O
doubt 79 84 2617 2622 O
will 85 89 2623 2627 O
be 90 92 2628 2630 O
required 93 101 2631 2639 O
to 102 104 2640 2642 O
use 105 108 2643 2646 B-contraception_consent
one 109 112 2647 2650 I-contraception_consent
of 113 115 2651 2653 I-contraception_consent
the 116 119 2654 2657 I-contraception_consent
contraception 120 133 2658 2671 I-contraception_consent
methods 134 141 2672 2679 I-contraception_consent
defined 142 149 2680 2687 O
in 150 152 2688 2690 O
protocol 153 161 2691 2699 O
if 162 164 2700 2702 O
they 165 169 2703 2707 O
wish 170 174 2708 2712 O
to 175 177 2713 2715 O
continue 178 186 2716 2724 O
their 187 192 2725 2730 O
HRT 193 196 2731 2734 O
during 197 203 2735 2741 O
the 204 207 2742 2745 O
study 208 213 2746 2751 O

Following 0 9 2752 2761 O
confirmation 10 22 2762 2774 O
of 23 25 2775 2777 O
their 26 31 2778 2783 O
post 32 36 2784 2788 O
- 36 37 2788 2789 O
menopausal 37 47 2789 2799 O
status 48 54 2800 2806 O
, 54 55 2806 2807 O
they 56 60 2808 2812 O
can 61 64 2813 2816 O
resume 65 71 2817 2823 O
use 72 75 2824 2827 O
of 76 78 2828 2830 O
HRT 79 82 2831 2834 B-treatment
during 83 89 2835 2841 O
the 90 93 2842 2845 O
study 94 99 2846 2851 O
without 100 107 2852 2859 O
use 108 111 2860 2863 B-contraception_consent
of 112 114 2864 2866 I-contraception_consent
a 115 116 2867 2868 I-contraception_consent
contraceptive 117 130 2869 2882 I-contraception_consent
method 131 137 2883 2889 I-contraception_consent

For 0 3 2890 2893 O
most 4 8 2894 2898 O
forms 9 14 2899 2904 O
of 15 17 2905 2907 O
HRT 18 21 2908 2911 B-treatment
, 21 22 2911 2912 O
at 23 25 2913 2915 O
least 26 31 2916 2921 O
two 32 35 2922 2925 B-lower_bound
to 36 38 2926 2928 O
four 39 43 2929 2933 B-upper_bound
weeks 44 49 2934 2939 I-upper_bound
will 50 54 2940 2944 O
elapse 55 61 2945 2951 O
between 62 69 2952 2959 O
the 70 73 2960 2963 O
cessation 74 83 2964 2973 O
of 84 86 2974 2976 O
therapy 87 94 2977 2984 B-treatment
and 95 98 2985 2988 O
the 99 102 2989 2992 O
blood 103 108 2993 2998 O
draw 109 113 2999 3003 O
; 113 114 3003 3004 O
this 115 119 3005 3009 O
interval 120 128 3010 3018 O
depends 129 136 3019 3026 O
on 137 139 3027 3029 O
the 140 143 3030 3033 O
type 144 148 3034 3038 O
and 149 152 3039 3042 O
dosage 153 159 3043 3049 O
of 160 162 3050 3052 O
HRT 163 166 3053 3056 O

GSK525762 0 9 3057 3066 B-treatment
is 10 12 3067 3069 O
a 13 14 3070 3071 O
benzodiazepine 15 29 3072 3086 B-treatment
class 30 35 3087 3092 O
molecule 36 44 3093 3101 O

Haematological 0 14 3102 3116 O
malignancy 15 25 3117 3127 B-cancer
associated 26 36 3128 3138 O
with 37 41 3139 3143 O
human 42 47 3144 3149 B-chronic_disease
immunodeficiency 48 64 3150 3166 I-chronic_disease
virus 65 70 3167 3172 I-chronic_disease
( 71 72 3173 3174 I-chronic_disease
HIV 72 75 3174 3177 I-chronic_disease
) 75 76 3177 3178 I-chronic_disease
infection 77 86 3179 3188 I-chronic_disease
or 87 89 3189 3191 O
solid 90 95 3192 3197 B-treatment
organ 96 101 3198 3203 I-treatment
transplant 102 112 3204 3214 I-treatment
or 113 115 3215 3217 O
history 116 123 3218 3225 O
of 124 126 3226 3228 O
known 127 132 3229 3234 O
Hepatitis 133 142 3235 3244 B-treatment
B 143 144 3245 3246 I-treatment
Antigen 145 152 3247 3254 I-treatment
or 153 155 3255 3257 O
positive 156 164 3258 3266 O
Hepatitis 165 174 3267 3276 B-treatment
C 175 176 3277 3278 I-treatment
antibody 177 185 3279 3287 I-treatment
( 186 187 3288 3289 O
confirmed 187 196 3289 3298 O
by 197 199 3299 3301 O
Recombinant 200 211 3302 3313 B-treatment
ImmunoBlot 212 222 3314 3324 I-treatment
Assay 223 228 3325 3330 I-treatment
[ 229 230 3331 3332 I-treatment
RIBA 230 234 3332 3336 I-treatment
] 234 235 3336 3337 I-treatment
, 235 236 3337 3338 O
if 237 239 3339 3341 O
available 240 249 3342 3351 O
or 250 252 3352 3354 O
alternately 253 264 3355 3366 O
confirmed 265 274 3367 3376 O
by 275 277 3377 3379 O
Hepatitis 278 287 3380 3389 B-chronic_disease
C 288 289 3390 3391 I-chronic_disease
Virus 290 295 3392 3397 I-chronic_disease
[ 296 297 3398 3399 I-chronic_disease
HCV 297 300 3399 3402 I-chronic_disease
] 300 301 3402 3403 I-chronic_disease
Ribonucleic 302 313 3404 3415 B-treatment
acid 314 318 3416 3420 I-treatment
[ 319 320 3421 3422 I-treatment
RNA 320 323 3422 3425 I-treatment
] 323 324 3425 3426 I-treatment
) 324 325 3426 3427 O

History 0 7 3428 3435 O
of 8 10 3436 3438 O
acute 11 16 3439 3444 B-chronic_disease
coronary 17 25 3445 3453 I-chronic_disease
syndromes 26 35 3454 3463 I-chronic_disease
( 36 37 3464 3465 O
including 37 46 3465 3474 O
unstable 47 55 3475 3483 B-chronic_disease
angina 56 62 3484 3490 I-chronic_disease
and 63 66 3491 3494 O
myocardial 67 77 3495 3505 B-chronic_disease
infarction 78 88 3506 3516 I-chronic_disease
) 88 89 3516 3517 O
, 89 90 3517 3518 O
coronary 91 99 3519 3527 B-treatment
angioplasty 100 111 3528 3539 I-treatment
, 111 112 3539 3540 O
or 113 115 3541 3543 O
stenting 116 124 3544 3552 B-treatment
within 125 131 3553 3559 O
the 132 135 3560 3563 O
past 136 140 3564 3568 B-upper_bound
3 141 142 3569 3570 I-upper_bound
months 143 149 3571 3577 I-upper_bound

History 0 7 3578 3585 O
of 8 10 3586 3588 O
major 11 16 3589 3594 O
gastrointestinal 17 33 3595 3611 B-chronic_disease
bleeding 34 42 3612 3620 I-chronic_disease
within 43 49 3621 3627 O
the 50 53 3628 3631 O
last 54 58 3632 3636 B-upper_bound
3 59 60 3637 3638 I-upper_bound
months 61 67 3639 3645 I-upper_bound
or 68 70 3646 3648 O
any 71 74 3649 3652 O
evidence 75 83 3653 3661 O
of 84 86 3662 3664 O
active 87 93 3665 3671 O
gastrointestinal 94 110 3672 3688 O
bleeding 111 119 3689 3697 O
excludes 120 128 3698 3706 O
the 129 132 3707 3710 O
subject 133 140 3711 3718 O

History 0 7 3719 3726 O
or 8 10 3727 3729 O
concurrent 11 21 3730 3740 O
malignancy 22 32 3741 3751 B-cancer
of 33 35 3752 3754 O
solid 36 41 3755 3760 O
tumours 42 49 3761 3768 B-cancer

History 0 7 3769 3776 O
or 8 10 3777 3779 O
current 11 18 3780 3787 O
clinically 19 29 3788 3798 O
significant 30 41 3799 3810 O
uncontrolled 42 54 3811 3823 O
arrhythmias 55 66 3824 3835 B-chronic_disease
or 67 69 3836 3838 O
hypertension 70 82 3839 3851 B-chronic_disease

History 0 7 3852 3859 O
or 8 10 3860 3862 O
evidence 11 19 3863 3871 O
of 20 22 3872 3874 O
current 23 30 3875 3882 O
> 31 32 3883 3884 O
= 32 33 3884 3885 O
Class 33 38 3885 3890 B-lower_bound
II 39 41 3891 3893 I-lower_bound
congestive 42 52 3894 3904 B-chronic_disease
heart 53 58 3905 3910 I-chronic_disease
failure 59 66 3911 3918 I-chronic_disease
as 67 69 3919 3921 O
defined 70 77 3922 3929 O
by 78 80 3930 3932 O
New 81 84 3933 3936 O
York 85 89 3937 3941 O
Heart 90 95 3942 3947 O
Association 96 107 3948 3959 O
( 108 109 3960 3961 O
NYHA 109 113 3961 3965 O
) 113 114 3965 3966 O

Hydroxyurea 0 11 3967 3978 B-treatment
for 12 15 3979 3982 O
proliferative 16 29 3983 3996 B-cancer
disease 30 37 3997 4004 I-cancer
, 37 38 4004 4005 O
Corticosteroids 39 54 4006 4021 B-treatment
, 54 55 4021 4022 O
Use 56 59 4023 4026 O
of 60 62 4027 4029 O
hematopoetic 63 75 4030 4042 O
growth 76 82 4043 4049 O
factors 83 90 4050 4057 O
is 91 93 4058 4060 O
permitted 94 103 4061 4070 O
at 104 106 4071 4073 O
the 107 110 4074 4077 O
discretion 111 121 4078 4088 O
of 122 124 4089 4091 O
the 125 128 4092 4095 O
investigator 129 141 4096 4108 O
according 142 151 4109 4118 O
to 152 154 4119 4121 O
published 155 164 4122 4131 O
guidelines 165 175 4132 4142 O
( 176 177 4143 4144 O
e.g. 177 181 4144 4148 O
, 181 182 4148 4149 O
National 183 191 4150 4158 O
Comprehensive 192 205 4159 4172 O
Cancer 206 212 4173 4179 O
Network 213 220 4180 4187 O
( 221 222 4188 4189 O
NCCN 222 226 4189 4193 O
) 226 227 4193 4194 O
, 227 228 4194 4195 O
American 229 237 4196 4204 O
Society 238 245 4205 4212 O
of 246 248 4213 4215 O
Clinical 249 257 4216 4224 O
Oncology 258 266 4225 4233 O
( 267 268 4234 4235 O
ASCO 268 272 4235 4239 O
) 272 273 4239 4240 O
, 273 274 4240 4241 O
American 275 283 4242 4250 O
Society 284 291 4251 4258 O
of 292 294 4259 4261 O
Hematology 295 305 4262 4272 O
( 306 307 4273 4274 O
ASH 307 310 4274 4277 O
) 310 311 4277 4278 O
, 311 312 4278 4279 O
etc 313 316 4280 4283 O
. 316 317 4283 4284 O
) 317 318 4284 4285 O

INR 0 3 4286 4289 B-clinical_variable
must 4 8 4290 4294 O
be 9 11 4295 4297 O
monitored 12 21 4298 4307 O
in 22 24 4308 4310 O
accordance 25 35 4311 4321 O
with 36 40 4322 4326 O
local 41 46 4327 4332 O
institutional 47 60 4333 4346 O
practices 61 70 4347 4356 O
, 70 71 4356 4357 O
as 72 74 4358 4360 O
appropriate 75 86 4361 4372 O

In 0 2 4373 4375 O
Part 3 7 4376 4380 O
1 8 9 4381 4382 O
and 10 13 4383 4386 O
, 13 14 4386 4387 O
Part 15 19 4388 4392 O
2 20 21 4393 4394 O
, 21 22 4394 4395 O
subjects 23 31 4396 4404 O
must 32 36 4405 4409 O
have 37 41 4410 4414 O
AML 42 45 4415 4418 B-cancer
, 45 46 4418 4419 O
MM 47 49 4420 4422 B-cancer
, 49 50 4422 4423 O
or 51 53 4424 4426 O
NHL 54 57 4427 4430 B-cancer

In 0 2 4431 4433 O
addition 3 11 4434 4442 O
, 11 12 4442 4443 O
male 13 17 4444 4448 B-gender
subjects 18 26 4449 4457 I-gender
whose 27 32 4458 4463 O
partners 33 41 4464 4472 O
are 42 45 4473 4476 O
or 46 48 4477 4479 O
become 49 55 4480 4486 B-pregnancy
pregnant 56 64 4487 4495 I-pregnancy
must 65 69 4496 4500 O
continue 70 78 4501 4509 O
to 79 81 4510 4512 O
use 82 85 4513 4516 B-contraception_consent
condoms 86 93 4517 4524 I-contraception_consent
for 94 97 4525 4528 O
7 98 99 4529 4530 B-lower_bound
days 100 104 4531 4535 I-lower_bound
after 105 110 4536 4541 I-lower_bound
stopping 111 119 4542 4550 O
study 120 125 4551 4556 O
medications 126 137 4557 4568 B-treatment

Investigational 0 15 4569 4584 O
anti 16 20 4585 4589 O
cancer 21 27 4590 4596 B-cancer
drug 28 32 4597 4601 O
within 33 39 4602 4608 O
2 40 41 4609 4610 B-upper_bound
weeks 42 47 4611 4616 I-upper_bound
prior 48 53 4617 4622 I-upper_bound
to 54 56 4623 4625 O
the 57 60 4626 4629 O
first 61 66 4630 4635 O
dose 67 71 4636 4640 O
of 72 74 4641 4643 O
GSK525762 75 84 4644 4653 B-treatment

Low 0 3 4654 4657 B-treatment
dose 4 8 4658 4662 I-treatment
( 9 10 4663 4664 I-treatment
prophylactic 10 22 4664 4676 I-treatment
) 22 23 4676 4677 I-treatment
low 24 27 4678 4681 B-treatment
molecular 28 37 4682 4691 I-treatment
weight 38 44 4692 4698 I-treatment
heparin 45 52 4699 4706 I-treatment
( 53 54 4707 4708 I-treatment
LMWH 54 58 4708 4712 I-treatment
) 58 59 4712 4713 I-treatment
is 60 62 4714 4716 O
permitted 63 72 4717 4726 O

Major 0 5 4727 4732 B-treatment
surgery 6 13 4733 4740 I-treatment
, 13 14 4740 4741 O
radiotherapy 15 27 4742 4754 B-treatment
, 27 28 4754 4755 O
or 29 31 4756 4758 O
immunotherapy 32 45 4759 4772 B-treatment
within 46 52 4773 4779 O
4 53 54 4780 4781 B-upper_bound
weeks 55 60 4782 4787 I-upper_bound
of 61 63 4788 4790 O
GSK525762 64 73 4791 4800 B-treatment

Male 0 4 4801 4805 B-gender
subjects 5 13 4806 4814 I-gender
must 14 18 4815 4819 O
agree 19 24 4820 4825 B-contraception_consent
to 25 27 4826 4828 I-contraception_consent
use 28 31 4829 4832 I-contraception_consent
one 32 35 4833 4836 I-contraception_consent
of 36 38 4837 4839 I-contraception_consent
the 39 42 4840 4843 I-contraception_consent
methods 43 50 4844 4851 I-contraception_consent
of 51 53 4852 4854 I-contraception_consent
contraception 54 67 4855 4868 I-contraception_consent
specified 68 77 4869 4878 I-contraception_consent

Males 0 5 4879 4884 B-gender

Negative 0 8 4885 4893 B-pregnancy
serum 9 14 4894 4899 I-pregnancy
pregnancy 15 24 4900 4909 I-pregnancy
test 25 29 4910 4914 O
< 30 31 4915 4916 O
= 31 32 4916 4917 O
7 33 34 4918 4919 B-upper_bound
days 35 39 4920 4924 I-upper_bound
prior 40 45 4925 4930 I-upper_bound
to 46 48 4931 4933 O
first 49 54 4934 4939 O
study 55 60 4940 4945 O
drug 61 65 4946 4950 O
dose 66 70 4951 4955 O

Nitrosourea 0 11 4956 4967 B-cancer
or 12 14 4968 4970 O
mitomycin 15 24 4971 4980 B-treatment
C 25 26 4981 4982 I-treatment
within 27 33 4983 4989 O
the 34 37 4990 4993 O
last 38 42 4994 4998 B-upper_bound
6 43 44 4999 5000 I-upper_bound
weeks 45 50 5001 5006 I-upper_bound

Otherwise 0 9 5007 5016 O
, 9 10 5016 5017 O
they 11 15 5018 5022 O
must 16 20 5023 5027 O
discontinue 21 32 5028 5039 O
HRT 33 36 5040 5043 B-treatment
to 37 39 5044 5046 O
allow 40 45 5047 5052 O
confirmation 46 58 5053 5065 O
of 59 61 5066 5068 O
post 62 66 5069 5073 O
- 66 67 5073 5074 O
menopausal 67 77 5074 5084 O
status 78 84 5085 5091 O
prior 85 90 5092 5097 O
to 91 93 5098 5100 O
study 94 99 5101 5106 O
enrolment 100 109 5107 5116 O

Presence 0 8 5117 5125 O
of 9 11 5126 5128 O
cardiac 12 19 5129 5136 B-treatment
pacemaker 20 29 5137 5146 I-treatment

Presence 0 8 5147 5155 O
of 9 11 5156 5158 O
gastrointestinal 12 28 5159 5175 B-chronic_disease
disease 29 36 5176 5183 I-chronic_disease
that 37 41 5184 5188 O
would 42 47 5189 5194 O
significantly 48 61 5195 5208 O
affect 62 68 5209 5215 O
compound 69 77 5216 5224 O
absorption 78 88 5225 5235 O

Subject 0 7 5236 5243 O
with 8 12 5244 5248 O
primary 13 20 5249 5256 B-cancer
CNS 21 24 5257 5260 I-cancer
lymphoma 25 33 5261 5269 I-cancer
( 34 35 5270 5271 O
defined 35 42 5271 5278 O
as 43 45 5279 5281 O
isolated 46 54 5282 5290 O
CNS 55 58 5291 5294 O
lymphoma 59 67 5295 5303 O
without 68 75 5304 5311 O
systemic 76 84 5312 5320 O
involvement 85 96 5321 5332 O
) 96 97 5332 5333 O
are 98 101 5334 5337 O
excluded 102 110 5338 5346 O
from 111 115 5347 5351 O
study 116 121 5352 5357 O

Subjects 0 8 5358 5366 O
who 9 12 5367 5370 O
have 13 17 5371 5375 O
been 18 22 5376 5380 O
disease 23 30 5381 5388 O
- 30 31 5388 5389 O
free 31 35 5389 5393 O
for 36 39 5394 5397 O
5 40 41 5398 5399 B-upper_bound
years 42 47 5400 5405 I-upper_bound
, 47 48 5405 5406 O
or 49 51 5407 5409 O
subjects 52 60 5410 5418 O
with 61 65 5419 5423 O
a 66 67 5424 5425 O
history 68 75 5426 5433 O
of 76 78 5434 5436 O
completely 79 89 5437 5447 O
resected 90 98 5448 5456 O
non 99 102 5457 5460 B-cancer
- 102 103 5460 5461 I-cancer
melanoma 103 111 5461 5469 I-cancer
skin 112 116 5470 5474 I-cancer
cancer 117 123 5475 5481 I-cancer
or 124 126 5482 5484 O
successfully 127 139 5485 5497 O
treated 140 147 5498 5505 O
in 148 150 5506 5508 O
situ 151 155 5509 5513 O
carcinoma 156 165 5514 5523 B-cancer
are 166 169 5524 5527 O
eligible 170 178 5528 5536 O

Subjects 0 8 5537 5545 O
with 9 13 5546 5550 O
AML 14 17 5551 5554 B-cancer
, 17 18 5554 5555 O
are 19 22 5556 5559 O
eligible 23 31 5560 5568 O
if 32 34 5569 5571 O
they 35 39 5572 5576 O
• 40 41 5577 5578 O
have 42 46 5579 5583 O
relapsed 47 55 5584 5592 O
and/or 56 62 5593 5599 O
refractory 63 73 5600 5610 B-cancer
disease 74 81 5611 5618 I-cancer
, 81 82 5618 5619 O
OR 83 85 5620 5622 O
are>=65 86 93 5623 5630 O
years 94 99 5631 5636 I-lower_bound
of 100 102 5637 5639 O
age 103 106 5640 5643 B-age
and 107 110 5644 5647 O
not 111 114 5648 5651 O
candidates 115 125 5652 5662 O
for 126 129 5663 5666 O
or 130 132 5667 5669 O
have 133 137 5670 5674 O
refused 138 145 5675 5682 O
standard 146 154 5683 5691 B-treatment
chemotherapy 155 167 5692 5704 I-treatment

Subjects 0 8 5705 5713 O
with 9 13 5714 5718 O
a 14 15 5719 5720 O
prior 16 21 5721 5726 O
history 22 29 5727 5734 O
of 30 32 5735 5737 O
stem 33 37 5738 5742 B-treatment
cell 38 42 5743 5747 I-treatment
transplant 43 53 5748 5758 I-treatment
( 54 55 5759 5760 O
autologous 55 65 5760 5770 B-treatment
and/or 66 72 5771 5777 O
allogeneic 73 83 5778 5788 B-treatment
) 83 84 5788 5789 O
are 85 88 5790 5793 O
allowed 89 96 5794 5801 O

Subjects 0 8 5802 5810 O
with 9 13 5811 5815 O
second 14 20 5816 5822 O
malignancies 21 33 5823 5835 B-cancer
that 34 38 5836 5840 O
are 39 42 5841 5844 O
indolent 43 51 5845 5853 O
or 52 54 5854 5856 O
definitively 55 67 5857 5869 O
treated 68 75 5870 5877 O
may 76 79 5878 5881 O
be 80 82 5882 5884 O
enrolled 83 91 5885 5893 O
even 92 96 5894 5898 O
if 97 99 5899 5901 O
less 100 104 5902 5906 O
than 105 109 5907 5911 O
5 110 111 5912 5913 B-upper_bound
years 112 117 5914 5919 I-upper_bound
have 118 122 5920 5924 O
elapsed 123 130 5925 5932 O
since 131 136 5933 5938 O
treatment 137 146 5939 5948 B-treatment

This 0 4 5949 5953 O
includes 5 13 5954 5962 O
excluding 14 23 5963 5972 O
current 24 31 5973 5980 O
medications 32 43 5981 5992 B-treatment
known 44 49 5993 5998 O
or 50 52 5999 6001 O
suspected 53 62 6002 6011 O
to 63 65 6012 6014 O
be 66 68 6015 6017 O
associated 69 79 6018 6028 O
QT 80 82 6029 6031 B-clinical_variable
prolongation 83 95 6032 6044 I-clinical_variable

This 0 4 6045 6049 O
method 5 11 6050 6056 O
must 12 16 6057 6061 O
be 17 19 6062 6064 O
used 20 24 6065 6069 O
from 25 29 6070 6074 O
the 30 33 6075 6078 O
time 34 38 6079 6083 O
of 39 41 6084 6086 O
the 42 45 6087 6090 O
first 46 51 6091 6096 O
dose 52 56 6097 6101 O
of 57 59 6102 6104 O
study 60 65 6105 6110 O
medication 66 76 6111 6121 B-treatment
until 77 82 6122 6127 O
16 83 85 6128 6130 O
weeks 86 91 6131 6136 O
after 92 97 6137 6142 O
the 98 101 6143 6146 O
last 102 106 6147 6151 O
dose 107 111 6152 6156 O
of 112 114 6157 6159 O
study 115 120 6160 6165 O
medication 121 131 6166 6176 O

Topical 0 7 6177 6184 B-treatment
steroids 8 16 6185 6193 I-treatment
are 17 20 6194 6197 O
permitted 21 30 6198 6207 O

Use 0 3 6208 6211 O
of 4 6 6212 6214 O
anticoagulants 7 21 6215 6229 B-treatment
( 22 23 6230 6231 O
e.g. 23 27 6231 6235 O
, 27 28 6235 6236 O
warfarin 29 37 6237 6245 B-treatment
, 37 38 6245 6246 O
heparin 39 46 6247 6254 B-treatment
) 46 47 6254 6255 O
at 48 50 6256 6258 O
therapeutic 51 62 6259 6270 B-clinical_variable
levels 63 69 6271 6277 I-clinical_variable
within 70 76 6278 6284 O
7 77 78 6285 6286 B-upper_bound
days 79 83 6287 6291 I-upper_bound
prior 84 89 6292 6297 I-upper_bound
to 90 92 6298 6300 O
the 93 96 6301 6304 O
first 97 102 6305 6310 O
dose 103 107 6311 6315 O
of 108 110 6316 6318 O
GSK525762 111 120 6319 6328 O

any 0 3 6329 6332 O
subject 4 11 6333 6340 O
who 12 15 6341 6344 O
is 16 18 6345 6347 O
expected 19 27 6348 6356 O
to 28 30 6357 6359 O
require 31 38 6360 6367 O
a 39 40 6368 6369 O
QT 41 43 6370 6372 B-clinical_variable
prolonging 44 54 6373 6383 O
medication 55 65 6384 6394 B-treatment
while 66 71 6395 6400 O
on 72 74 6401 6403 O
trial 75 80 6404 6409 O
should 81 87 6410 6416 O
not 88 91 6417 6420 O
be 92 94 6421 6423 O
enrolled 95 103 6424 6432 O

at 0 2 6433 6435 O
least 3 8 6436 6441 O
28 9 11 6442 6444 B-lower_bound
days 12 16 6445 6449 I-lower_bound
( 17 18 6450 6451 O
whichever 18 27 6451 6460 O
is 28 30 6461 6463 O
longer 31 37 6464 6470 O
) 37 38 6470 6471 O
following 39 48 6472 6481 O
the 49 52 6482 6485 O
last 53 57 6486 6490 O
dose 58 62 6491 6495 O
of 63 65 6496 6498 O
study 66 71 6499 6504 O
treatment 72 81 6505 6514 B-treatment

females 0 7 6515 6522 B-gender

the 0 3 6523 6526 O
subject 4 11 6527 6534 O
has 12 15 6535 6538 O
been 16 20 6539 6543 O
off 21 24 6544 6547 O
systemic 25 33 6548 6556 O
immunosuppressive 34 51 6557 6574 B-treatment
medications 52 63 6575 6586 I-treatment
( 64 65 6587 6588 O
including 65 74 6588 6597 O
but 75 78 6598 6601 O
not 79 82 6602 6605 O
limited 83 90 6606 6613 O
to 91 93 6614 6616 O
: 93 94 6616 6617 O
cyclosporine 95 107 6618 6630 B-treatment
, 107 108 6630 6631 O
tacrolimus 109 119 6632 6642 B-treatment
, 119 120 6642 6643 O
mycophenolate 121 134 6644 6657 B-treatment
mofetil 135 142 6658 6665 I-treatment
, 142 143 6665 6666 O
or 144 146 6667 6669 O
corticosteroids 147 162 6670 6685 B-treatment
) 162 163 6685 6686 O
for 164 167 6687 6690 O
at 168 170 6691 6693 O
least 171 176 6694 6699 O
1 177 178 6700 6701 B-lower_bound
month 179 184 6702 6707 I-lower_bound
prior 185 190 6708 6713 I-lower_bound
to 191 193 6714 6716 O
the 194 197 6717 6720 O
first 198 203 6721 6726 O
dose 204 208 6727 6731 O
of 209 211 6732 6734 O
GSK525762 212 221 6735 6744 B-treatment

the 0 3 6745 6748 O
subject 4 11 6749 6756 O
has 12 15 6757 6760 O
recovered 16 25 6761 6770 O
from 26 30 6771 6775 O
transplant 31 41 6776 6786 B-treatment
- 41 42 6786 6787 O
associated 42 52 6787 6797 O
toxicities 53 63 6798 6808 O
prior 64 69 6809 6814 O
to 70 72 6815 6817 O
the 73 76 6818 6821 O
first 77 82 6822 6827 O
dose 83 87 6828 6832 O
of 88 90 6833 6835 O
GSK525762 91 100 6836 6845 O
, 100 101 6845 6846 O
and 102 105 6847 6850 O
For 106 109 6851 6854 O
subjects 110 118 6855 6863 O
with 119 123 6864 6868 O
a 124 125 6869 6870 O
prior 126 131 6871 6876 O
history 132 139 6877 6884 O
of 140 142 6885 6887 O
allogeneic 143 153 6888 6898 B-treatment
transplant 154 164 6899 6909 I-treatment

there 0 5 6910 6915 O
are 6 9 6916 6919 O
no 10 12 6920 6922 O
signs 13 18 6923 6928 O
or 19 21 6929 6931 O
symptoms 22 30 6932 6940 O
of 31 33 6941 6943 O
graft 34 39 6944 6949 B-chronic_disease
versus 40 46 6950 6956 I-chronic_disease
host 47 51 6957 6961 I-chronic_disease
disease 52 59 6962 6969 I-chronic_disease
, 59 60 6969 6970 O
other 61 66 6971 6976 O
than 67 71 6977 6981 O
Grade 72 77 6982 6987 O
1 78 79 6988 6989 O
skin 80 84 6990 6994 O
involvement 85 96 6995 7006 O

